“No longer do we want to talk about the potential of the UK as a scientific superpower. We want to talk about the reality of it,” said GlaxoSmithKlein chair Sir Jonathan Symonds as he opened EG and Bidwell’s
Thank you for reading EG
Want to read more? Enjoy a story a week for FREE for one month.
